about
Nutrigenomics and Cancer Prevention.Gut microbes, diet, and cancer.Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.Gut microbiome and anticancer immune response: really hot Sh*t!Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials.Emerging roles of the microbiome in cancer.Bacteria, food, and cancer.Estrogens and prostate cancer: etiology, mediators, prevention, and management.Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.The microbiome and its potential as a cancer preventive intervention.The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4GEquol-producing status, isoflavone intake, and breast density in a sample of U.S. Chinese women.Equol production changes over time in postmenopausal women.Emerging evidence of the health benefits of S-equol, an estrogen receptor β agonist.Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies.In Vitro Anticancer Activity of Au, Ag Nanoparticles Synthesized Using Commelina nudiflora L. Aqueous Extract Against HCT-116 Colon Cancer Cells.Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer.Relationship of equol production between children aged 5-7 years and their mothers.The isoflavone irilone contributes to the estrogenic potential of dietary supplements containing red clover.Fertility and growth of nulliparous ewes after feeding red clover silage with high phyto-oestrogen concentrations.Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.Drug Targeting of the Human MicrobiomeA prospective evaluation of plasma polyphenol levels and colon cancer risk
P2860
Q33719986-0B1D2109-A827-4B13-BEA4-C591BF500A73Q34000541-C058522E-AF7C-40CD-95A9-010459B895EAQ34303495-3BCD4D84-D67C-48F3-9305-782EE6B9B55AQ34723570-36C8A485-59D8-4D9D-8E5B-E543445436B0Q34924272-51D06BF3-BEB3-46AC-80B2-A248FA64A401Q34992997-FC1688EF-0225-4ED1-8FAC-29E0AFF3C829Q35058372-EEAFFBF7-C3B1-461B-AC62-0CE3335A97A4Q35161556-3846726E-D3E1-49D4-B4BD-A1790825DB44Q35196710-B7F257C8-75C2-4EC7-8AA2-0C0748FDB412Q35629651-9F53F4AC-9C15-4520-97B1-277DF89CCF68Q35954984-01D303F3-AE7D-410B-A669-4B6036B91DC0Q36451858-FDF368F5-E6B9-4A49-BECC-9613AEAF00A0Q37324699-EFAF04DA-946C-4C50-82D3-D3A114FE53C6Q37512708-5288459A-0D3B-4B1B-85B2-918DC1D36370Q37905857-37050480-9212-4394-97D2-05E22FDF83DDQ38558029-E1402332-8620-49AB-965E-DE3AD57155DAQ38787515-5E77EB3E-48F4-43FC-8413-546A309E2D89Q40105271-3D8A5B0B-DC85-4209-A2B5-2905CE6342F8Q40721715-D25A6518-0748-4F0F-93EF-A62ED5233DD9Q42709705-50A0F0AC-1B6D-4497-B52F-1477AE0970B2Q50467251-D95865AB-7B6F-47A2-AFF0-ADA2DC31BE08Q54684671-AE673A2A-6B57-4208-87E2-94EE831186F8Q57265205-7FE23212-90A7-4F32-BFDA-D3B0B3D38EC3Q57417055-45830C4E-4369-4D5B-ABD3-DE5E31F0E294
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Emerging research on equol and cancer
@ast
Emerging research on equol and cancer
@en
type
label
Emerging research on equol and cancer
@ast
Emerging research on equol and cancer
@en
prefLabel
Emerging research on equol and cancer
@ast
Emerging research on equol and cancer
@en
P2860
P356
P1433
P1476
Emerging research on equol and cancer
@en
P2093
Johanna W Lampe
P2860
P304
P356
10.3945/JN.109.118323
P407
P577
2010-05-26T00:00:00Z